Alterations of Insulin Resistance and the Serum Adiponectin Level in Patients with Type 2 Diabetes Mellitus Under the Usual Antihypertensive Dosage of Telmisartan Treatment

2010 ◽  
Vol 12 (5) ◽  
pp. 393-398 ◽  
Author(s):  
Yoshinobu Fuke ◽  
Takayuki Fujita ◽  
Atsushi Satomura ◽  
Yuki Wada ◽  
Koichi Matsumoto
Keyword(s):  
Diabetes Mellitus ◽  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Adiponectin Level ◽  
Serum Adiponectin ◽  
Serum Adiponectin Level

scholarly journals Type 2 diabetes mellitus is associated with lower serum adiponectin level in Bangladeshi population

Mediscope ◽  
2015 ◽  
Vol 2 (2) ◽  
pp. 16-21
Author(s):  
SN Eva ◽  
GM Mollah ◽  
DK Sunyal ◽  
R Zinnat
Keyword(s):  
Diabetes Mellitus ◽  
Insulin Resistance ◽  
Adiponectin Level ◽  
Serum Insulin ◽  
Serum Adiponectin ◽  
Serum Adiponectin Level ◽  
Lower Serum ◽  
Control Subjects ◽  
Bangladeshi Population

The  aim  of  the  observational  case  control  study  was  to  find  out  the  association  of  type  2  diabetes  mellitus  (T2DM)  with  serum  adiponectin  level  in  Bangladeshi  population.  This  was  conducted  in  the  Biomedical  Research  Group,  Research  Division,  Bangladesh  Institute  of  Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka,  Bangladesh.  Sixty six T2DM subjects and seventy four healthy control subjects were included.  Diabetes  was  diagnosed  and  classified  as  per  World  Health  Organization  criteria.  Serum  adiponectin was measured by Enzyme Linked Immunosorbent Assay (ELISA) method. Serum  glucose  was  measured  by  glucose-oxidase  method;  serum  insulin  was  measured  by  chemiluminescence- based ELISA technique. The insulin secretory capacity (HOMA%B), insulin  sensitivity  (HOMA%S)  &  insulin  resistance  (HOMA-IR)  were  assayed  by  homeostasis  model  assessment method. Statistical analysis was performed using SPSS Windows version 11.5. The  median  (range)  fasting  serum  insulin  of  control  and T2DM subjects  were  14.7  (1.9-45.9)  and  18.1 (4.1-42.8), respectively. The median (range) serum adiponectin (?g/ml) of the control and  T2DM  subjects  were  8.7  (0.8-16.0)  and  6.2  (1.1-22.4).  The  serum  adiponectin  of  T2DM  was  significantly lower than the control subjects (p < 0.001). The median (range) HOMA%B values  of control and T2DM subjects were 160.1 (33.4-493.4) and 100.5 (17.7-349.3), respectively. The  median  HOMA%B  of  T2DM  subjects  was  significantly  lower  than  the  control  subjects  (p  <  0.001).  The  median  (range)  HOMA%S  values  of  control  and  T2DM  subjects  were  44.2  (9.8-339.4)  and  32.8  (14.3-154.7),  respectively.  The  median  HOMA%S  of  T2DM  group  was  significantly lower than the control subjects (p < 0.05). The median (range) HOMA-IR of control  and T2DM subjects were 3.5 (0.5-11.4) and 5.8 (1.0-28.3), respectively. The median HOMA-IR  of T2DM subjects was significantly higher than the control subjects (p < 0.001). The results of  the  study  suggest  that  T2DM  subjects  have  both  insulin  secretory  defects,  insulin  resistance  and associated with lower serum adiponectin level in Bangladeshi population.Mediscope Vol. 2, No. 2: July 2015, Pages 16-21

Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population

Metabolism ◽  
2008 ◽  
Vol 57 (8) ◽  
pp. 1130-1134 ◽  
Author(s):  
Kirsti Jalovaara ◽  
Merja Santaniemi ◽  
Markku Timonen ◽  
Jari Jokelainen ◽  
Y. Antero Kesäniemi ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Adiponectin Level ◽  
Glucose Regulation ◽  
Impaired Glucose Regulation ◽  
Finnish Population ◽  
Serum Adiponectin Level ◽  
Low Serum

scholarly journals Study of serum adiponectin levels for early detection of type 2 diabetes mellitus and its complications on kidney

2021 ◽  
Vol 8 (2) ◽  
pp. 171
Author(s):  
Harish K. V. ◽  
Hareesh R. ◽  
Akshatha Savith
Keyword(s):  
Diabetes Mellitus ◽  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Diabetic Nephropathy ◽  
Early Detection ◽  
Serum Adiponectin ◽  
Healthy Controls ◽  
Newly Diagnosed

Background: Type 2 diabetes mellitus is a chronic metabolic disorder due to insulin resistance caused by destruction of beta cells of pancreas. Insulin resistance in newly diagnosed type 2 diabetes mellitus patients leads to hyperglycemia. Serum adiponectin is a more sensitive and specific biomarker for early detection of diabetic nephropathy than urinary microalbuminuria.Methods: This is a case-control study conducted in Akash Institute of Medical Sciences, A total 180 subjects (120 cases and 60 controls). All the subjects included after informed consent, blood samples and urine samples are collected from the all the subjects. The serum Adiponectin and was estimated by using enzyme-linked immunoassay (ELISA) and fasting blood sugar (FBS), post prandial blood sugar (PPBS) and renal function test (RFT) was also estimated by laboratory standard methods.Results: This study was evaluated the FBS, PPBS, RFT and serum adiponectin levels in patients with type 2 diabetes mellitus patients and compare them with healthy controls. The serum adiponectin levels more significantly elevated in newly diagnosed type 2 diabetes mellitus patients and compared with the healthy controls. The study also found that significantly elevated levels of FBS, PPBS and RFT in type 2 diabetes mellitus patients and compared with the healthy controls, The statistically significant levels of serum adiponectin in patients with type 2 diabetes mellitus and when compared with the controls (p= 0.0001).Conclusions: The study suggesting that the s estimation of serum adiponectin levels in newly diagnosed type 2 diabetes mellitus patients useful for early detection of diabetic nephropathy. Because elevated levels of serum adiponectin in patients with newly diagnosed type 2 diabetes mellitus, this levels are positively correlated with the FBS and PPBS. 

scholarly journals Association between Adiponectin and Insulin Resistance among Sudanese Males with Type 2 Diabetes Mellitus

2021 ◽  
Author(s):  
Eman Ahamed Almakey ◽  
Ahmed Mohamed Makeen ◽  
Osman Khalafalla Saeed ◽  
Khalid Abdelsamea Mohamedahmed
Keyword(s):  
Diabetes Mellitus ◽  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Serum Adiponectin ◽  
Control Group ◽  
P Value ◽  
Model Assessment ◽  
Positive Effects

Abstract Background Adiponectin is associated with improved systemic insulin sensitivity and profound positive effects in adipose tissue, such as increasing mitochondrial density in adipocytes, reducing adipocyte size, and effective esterification of free fatty acids on lipid storage The factor performs forward transcriptional regulation. Diabetes and its complications are considered to be one of the main causes of morbidity and mortality worldwide. Objectives The aim of this study was to correlate serum levels of adiponectin with insulin resistance in Sudanese males' type 2 diabetes mellitus. Methodology: A case-control community-based study carried out among 126 patients with T2DM as cases group (mean ages 45.2 ± 5.4 years); and 126 normal healthy individuals as controls group (mean ages 44.7 ± 5.4 years as) in Aldaraga Diabetic Center, Wad Medani, Gezira State, Sudan. About Five mL of fasting venous blood was obtained from all participants. HbA1c, FPG, FPI, serum Adiponectin, and (HOMA)-IR were analyzed. SPSS (v 20.0) was used for data analysis. Results The mean of serum adiponectin in the cases group (3.03 ± 0.90µg/ml) was lower than the control group (6.02 ± 4.24µg/ml) giving highly significant differences -between them (P = value ≤ 0.000). HbA1c and Homeostasis Model Assessment of Insulin Resistance index (HOMA-IR) differed significantly between the two groups (P-value ≤ 0.000). Serum adiponectin concentrations correlated significantly negative with HOMA IR (r = -0.149, P-value = 0.002). Conclusion We concluded that low plasma adiponectin level was predictive of future development of Insulin resistance in Sudanese males.

scholarly journals Type 2 Diabetes Mellitus is Associated with Lower Serum Adiponectin Level in Bangladeshi Population

2015 ◽  
Vol 6 (1) ◽  
pp. 10-13
Author(s):  
Sohely Nazneen Eva ◽  
Rahelee Zinnat ◽  
Golam Morshed Molla ◽  
Muneera Zahir ◽  
Fatema Akter ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
Adiponectin Level ◽  
Serum Insulin ◽  
Serum Adiponectin ◽  
Enzyme Linked Immunosorbent Assay ◽  
Serum Adiponectin Level ◽  
Lower Serum ◽  
Control Subjects

Background: The physiological role of adiponectin is not yet fully clear, but it is now generally accepted that it has a protective role against the development of lifestyle disorders, related to insulin resistance and atherosclerosis. Insulin resistance is one of the basic defects of type 2 diabetes (T2DM) and adiponectin is inversely associated with T2DM. As serum adiponectin level has not yet been investigated in Bangladeshi T2DM subjects,so that the present study has been under taken to find out the association of T2DM with serum adiponectin level in Bangladeshi population.Methodology: In this observational case control study, sixty six (66) T2DM subjects, seventy four (74) healthy control subjects were included. Diabetes was diagnosed and classified as per WHO criteria. Serum Adiponectin was measured by Enzyme Linked Immunosorbent Assay (ELISA) method. Serum glucose was measured by glucose-oxidase method; serum insulin was measured by chemiluminescence-based ELISA technique. The insulin secretory capacity (HOMA%B), insulin sensitivity (HOMA%S) & insulin resistance (HOMA IR) were assayed by homeostasis model assessment method.Results: The study subjects were BMI matched. BMI of the Control subjects and T2DM subjects (Mean±SD) were 25.02±3.55 and 25.85±3.62. Age (year) of the Control subjects and T2DM subjects (Mean±SD) were 42.46±9.24 and 48.49±8.09. Median (range) fasting serum insulin in the control and T2DM was 14.68 (1.86-45.92) and 18.09 (4.10-42.78) respectively which was not statistically significant (p=0.214). Median (range) HOMA%B values in the control and T2DM subjects was 160.10(33.40-493.40) and 100.45(17.70-349.30). Median HOMA%B in the T2DM group was significantly lower compared to the control (p=0.0001). Median (range) HOMA%S values in the control and T2DM subjects was 44.20(9.80- 339.40) and 32.80(14.30-154.70) respectively. Median HOMA%S in the T2DM group was significantly lower compared to the control (p=0.036). Median (range) serum adiponectin (?g/ml) of the control and T2DM subjects was 8.70 (0.76-15.96) and 6.19 (1.13-22.37). Serum adiponectin was significantly lower in T2DM compared to the control (p=0.0001).Conclusions: From this study it may be concluded that, T2DM subjects have both insulin secretory defects and insulin resistance and associated with lower serum adiponectin level in Bangladeshi population.Anwer Khan Modern Medical College Journal Vol. 6, No. 1: January 2015, Pages 10-13

scholarly journals Serum resistin and adiponectin relationships with glucometabolic control in patients with type 2 diabetes mellitus

2018 ◽  
Vol 146 (5-6) ◽  
pp. 285-290
Author(s):  
Regaeiy Al ◽  
Syed Habib ◽  
Dokhi Al ◽  
Anwar Jammah ◽  
Mohammad Subhan
Keyword(s):  
Diabetes Mellitus ◽  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
The Body ◽  
Poor Glycemic Control ◽  
Serum Adiponectin ◽  
Control Subjects

Introduction/Objective. Adiponectin and resistin are important adipokines that play an important role in the regulation of blood sugar, beta-oxidation in muscles, and insulin resistance. This study aimed to assess and compare the relationships of resistin and adiponectin concentrations with glucometabolic control in patients with type 2 diabetes mellitus (T2DM). Methods. A total of 191 subjects were studied. The final selection included 107 patients with T2DM (67 males and 40 females) and 84 healthy control subjects (45 males and 39 females). Fasting venous blood samples were analyzed for glucose (FBG), glycosylated hemoglobin (HbA1c), insulin, lipids, adiponectin and resistin levels. Body composition was evaluated in all subjects by the body mass index (BMI) and waist?hip ratio (WHR). Results. BMI, WHR, FBG, HbA1c, homeostatic model assessment of insulin resistance (HOMA-IR), total cholesterol, and triglycerides were significantly higher in individuals with T2DM compared to healthy volunteers. Serum resistin levels were significantly higher (p = 0.0259) and serum adiponectin levels were significantly lower (p = 0.0001) in T2DM patients than in control subjects. Adiponectin levels were significantly lower (p = 0.0411) in diabetes patients with poor glycemic control, compared to those with good glycemic control, while the difference was non-significant for resistin (p = 0.8899). Serum adiponectin levels were discordant with HbA1c (r = -0.274, p = 0.004). Linear-by-linear association showed significant trend of better glycemic control at increasing quartiles of adiponectin levels (p = 0.042), while the trend was not significant for resistin levels (p = 0.904). Multiple regression analysis revealed FBG, insulin, HOMA-IR, and HbA1c as significant predictors of adiponectin. Conclusions. T2DM patients have significantly higher resistin and lower adiponectin levels compared to healthy controls. Adiponectin levels were significantly lower in patients with poor glycemic control.

Sign in / Sign up

Export Citation Format

Share Document